ZymoGenetics, Inc. · Seattle, WA United States ·(NASDAQ (GM): ZGEN)
Company Description
View ZymoGenetics, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window ZymoGenetics has proteins on its plate. The firm culls genomics databases to indentify and develop protein-based drugs targeting a variety conditions, including autoimmune diseases and cancer. Its sole commercial product, RECOTHROM (rThrombin), controls bleeding during surgery. Unlike existing forms of thrombin, RECOTHROM is derived from recombinant proteins instead of animal or human blood, which can trigger adverse reactions. The company's pipeline also includes cancer treatments Interleukin 21 and Atacicept. Novo Nordisk owned ZymoGenetics for a dozen years and still holds a 30% stake in the company. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key ZymoGenetics, Inc. Financials
| Company Type | Public - NASDAQ (GM): ZGEN Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $74.0 |
| 2008 Employees | 530 |
ZymoGenetics, Inc. Executives
18 executives listed for ZymoGenetics, Inc.'s Seattle, WA location.
| Title | Name & Bio | Contact |
| Chairman | Bruce Carter | Network |
| CEO and Director | Douglas Williams | Network |
| President; General Manager, Biosurgery Business Unit | Stephen Zaruby | Network |
Competition
Competitive Landscape for ZymoGenetics, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top ZymoGenetics, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!